Related Experiment Video
Updated: May 4, 2026
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.8K
Predictors of chronic obstructive pulmonary disease exacerbations
1aRespiratory Care Clinic, Nippon Medical School bDepartment of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Current Opinion in Pulmonary Medicine
|January 11, 2014
Summary
Identifying genetic factors, like Siglec-14, is crucial for predicting frequent exacerbations in chronic obstructive pulmonary disease (COPD). Understanding these genetic predictors can lead to new therapeutic strategies for COPD management.
Area of Science:
- Pulmonology
- Genetics
- Immunology
Background:
- A distinct phenotype of chronic obstructive pulmonary disease (COPD) characterized by frequent exacerbations exists, irrespective of overall disease severity.
- Predicting individuals prone to frequent exacerbations is essential for targeted management and intervention.
- Current research focuses on identifying reliable predictors for COPD exacerbations.
Purpose of the Study:
- To critically review recent literature on predicting COPD exacerbations.
- To identify key factors, including genetic and inflammatory markers, associated with exacerbation risk.
- To provide recommendations for future research directions in COPD exacerbation prediction.
Main Methods:
- Literature review of recent studies on COPD exacerbation predictors.
- Analysis of inflammatory biomarkers and genetic polymorphisms.
- Evaluation of the role of specific proteins like Siglec-14 in COPD exacerbations.
Main Results:
- Inflammatory biomarkers may reflect consequences rather than causes of exacerbations.
- Genetic polymorphisms are implicated in the causal pathways of COPD exacerbations.
- Loss of Siglec-14, a host defense lectin, was associated with a reduced risk of COPD exacerbations.
Conclusions:
- Genetic factors, such as Siglec-14, play a significant role in COPD exacerbation risk.
- Understanding the role of host defense proteins like Siglec-14 is vital for elucidating COPD pathogenesis.
- Targeting genetic pathways may offer novel therapeutic strategies for managing frequent COPD exacerbations and associated comorbidities.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:23Chronic Obstructive Pulmonary Disease I: Introduction
33
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.4K